Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Double-spin PRP is more effective for treating male pattern baldness.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Deucravacitinib helped a man regrow hair significantly.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib is effective for severe alopecia areata but has some side effects.

Certain NK cell changes in blood may indicate alopecia areata progression.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Changes in skin bacteria may relate to alopecia areata severity.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

Intralesional vitamin D is mildly effective for treating Alopecia Areata.